21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications

From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy lifespan continue to lag behind, Charlie Bryant at Androlabs explores how pharma could help improve this by shifting its focus from treatment to prevention

Tina Backhouse from Theramex on the treatment access challenges women face

Dr Werner Engelbrecht at Veeva Systems discusses how compliance can be turned into a competitive advantage with connected platforms and data, AI-driven efficiencies and new patient-centric models

Too often in discussions about the COVID-19 pandemic it is treated like a finished and finalised event. Anu Osinusi at Gilead Sciences explores how its impacts are still being felt by patients and healthcare organisations around the globe

Julie Missaggia at CMI Media Group, a WPP Company, and Compas, explores how workplaces engage with the symptoms of menopause, and why this needs to be improved

With a region as large and diverse as Europe, Mike Ryan and Paolo Correale at EVERSANA explain how pharma companies can best engage with the myriad of expectations and regulations associated with launching in the EU

In Pharmafocus’ inaugural Leader in Focus, Şeyda Atadan Memiş at Takeda UK and Ireland reflects on her career and explains the importance of providing more support to get women into STEM

Ruthie Davi and Elizabeth Lamont at Medidata AI discuss how adopting different approaches, such as synthetic control arms and remote monitoring, can aid researchers in investigating rare diseases.

Vikas Jain at Tata Consultancy Services examines three key avenues for AI to be adopted by the pharma industry and the benefits that each adoption can have.

Improving patient experience is increasingly recognised as essential to enhancing healthcare quality, satisfaction and health outcomes across the globe. By understanding the unique challenges and opportunities in different regions, healthcare systems can develop more effective, patient-centred care models.

Dr Mark Bunnage, Senior Vice President and Head of Global Research at Vertex Pharmaceuticals, talks to Pharmafocus about scientific innovation to help create transformative medicines for people living with serious diseases